Skip to main content
Premium Trial:

Request an Annual Quote

BioArray Solutions Gets FDA Clearance for Bead Array Immunoassay

NEW YORK, June 15 (GenomeWeb News) - BioArray Solutions has received clearance from the US Food and Drug Administration for a bead array-based multiplexed immunoassay, the Warren, NJ-based company said today.

 

The 510(k) clearance covers the company's IgG BeadChip test system, an immunoassay for the simultaneous detection of six antibodies to different extractable nuclear antigens. The test will be used with BioArray's Array Imaging Ssystem, AIS 400, which employs a chip format for detection.

 

BioArray Solutions is currently developing other assays for protein and DNA analysis to run on its platform.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.